PRGO
Price
$22.27
Change
-$0.28 (-1.24%)
Updated
Sep 12 closing price
Capitalization
3.06B
53 days until earnings call
ZTS
Price
$148.20
Change
-$2.41 (-1.60%)
Updated
Sep 12 closing price
Capitalization
65.68B
47 days until earnings call
Interact to see
Advertisement

PRGO vs ZTS

Header iconPRGO vs ZTS Comparison
Open Charts PRGO vs ZTSBanner chart's image
Perrigo
Price$22.27
Change-$0.28 (-1.24%)
Volume$1.33M
Capitalization3.06B
ZOETIS
Price$148.20
Change-$2.41 (-1.60%)
Volume$3.11M
Capitalization65.68B
PRGO vs ZTS Comparison Chart in %
Loading...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRGO vs. ZTS commentary
Sep 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRGO is a Hold and ZTS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 13, 2025
Stock price -- (PRGO: $22.27 vs. ZTS: $148.20)
Brand notoriety: PRGO: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: PRGO: 87% vs. ZTS: 101%
Market capitalization -- PRGO: $3.06B vs. ZTS: $65.68B
PRGO [@Pharmaceuticals: Generic] is valued at $3.06B. ZTS’s [@Pharmaceuticals: Generic] market capitalization is $65.68B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $65.68B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRGO’s FA Score shows that 1 FA rating(s) are green whileZTS’s FA Score has 1 green FA rating(s).

  • PRGO’s FA Score: 1 green, 4 red.
  • ZTS’s FA Score: 1 green, 4 red.
According to our system of comparison, both PRGO and ZTS are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRGO’s TA Score shows that 4 TA indicator(s) are bullish while ZTS’s TA Score has 3 bullish TA indicator(s).

  • PRGO’s TA Score: 4 bullish, 5 bearish.
  • ZTS’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, PRGO is a better buy in the short-term than ZTS.

Price Growth

PRGO (@Pharmaceuticals: Generic) experienced а -1.68% price change this week, while ZTS (@Pharmaceuticals: Generic) price change was -3.34% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.26%. For the same industry, the average monthly price growth was +4.29%, and the average quarterly price growth was +53.41%.

Reported Earning Dates

PRGO is expected to report earnings on Nov 05, 2025.

ZTS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($65.7B) has a higher market cap than PRGO($3.06B). PRGO has higher P/E ratio than ZTS: PRGO (2818.00) vs ZTS (25.51). ZTS YTD gains are higher at: -8.152 vs. PRGO (-10.457). ZTS has higher annual earnings (EBITDA): 4.02B vs. PRGO (612M). ZTS has more cash in the bank: 1.44B vs. PRGO (454M). PRGO has less debt than ZTS: PRGO (3.65B) vs ZTS (6.79B). ZTS has higher revenues than PRGO: ZTS (9.39B) vs PRGO (4.33B).
PRGOZTSPRGO / ZTS
Capitalization3.06B65.7B5%
EBITDA612M4.02B15%
Gain YTD-10.457-8.152128%
P/E Ratio2818.0025.5111,048%
Revenue4.33B9.39B46%
Total Cash454M1.44B32%
Total Debt3.65B6.79B54%
FUNDAMENTALS RATINGS
PRGO vs ZTS: Fundamental Ratings
PRGO
ZTS
OUTLOOK RATING
1..100
5673
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9219
PRICE GROWTH RATING
1..100
5050
P/E GROWTH RATING
1..100
286
SEASONALITY SCORE
1..100
9075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (50) in the Pharmaceuticals Other industry is in the same range as ZTS (50) in the Pharmaceuticals Generic industry. This means that PRGO’s stock grew similarly to ZTS’s over the last 12 months.

PRGO's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ZTS (100) in the Pharmaceuticals Generic industry. This means that PRGO’s stock grew similarly to ZTS’s over the last 12 months.

ZTS's SMR Rating (19) in the Pharmaceuticals Generic industry is significantly better than the same rating for PRGO (92) in the Pharmaceuticals Other industry. This means that ZTS’s stock grew significantly faster than PRGO’s over the last 12 months.

ZTS's Price Growth Rating (50) in the Pharmaceuticals Generic industry is in the same range as PRGO (50) in the Pharmaceuticals Other industry. This means that ZTS’s stock grew similarly to PRGO’s over the last 12 months.

PRGO's P/E Growth Rating (2) in the Pharmaceuticals Other industry is significantly better than the same rating for ZTS (86) in the Pharmaceuticals Generic industry. This means that PRGO’s stock grew significantly faster than ZTS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PRGOZTS
RSI
ODDS (%)
Bullish Trend 1 day ago
76%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
60%
Momentum
ODDS (%)
Bearish Trend 1 day ago
59%
Bearish Trend 1 day ago
66%
MACD
ODDS (%)
Bearish Trend 1 day ago
63%
Bearish Trend 1 day ago
58%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
57%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 1 day ago
59%
Advances
ODDS (%)
Bullish Trend 25 days ago
61%
Bullish Trend 9 days ago
56%
Declines
ODDS (%)
Bearish Trend 4 days ago
65%
Bearish Trend 4 days ago
57%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 1 day ago
61%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
44%
View a ticker or compare two or three
Interact to see
Advertisement
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMOCX18.47N/A
N/A
Victory RS Mid Cap Growth C
DRLYX8.89N/A
N/A
BNY Mellon Developed Markets RE Scs - Y
VEXRX113.43N/A
N/A
Vanguard Explorer Adm
BFGUX53.93-0.05
-0.10%
Baron Focused Growth R6
SSHFX41.13-0.07
-0.17%
Sound Shore Investor

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with ORGO. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then ORGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
-1.24%
ORGO - PRGO
46%
Loosely correlated
-2.18%
EOLS - PRGO
43%
Loosely correlated
-4.26%
AMRX - PRGO
38%
Loosely correlated
-0.89%
PBH - PRGO
35%
Loosely correlated
-2.72%
ZTS - PRGO
32%
Poorly correlated
-1.60%
More

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with VTRS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
-1.60%
VTRS - ZTS
46%
Loosely correlated
-2.06%
ELAN - ZTS
45%
Loosely correlated
-1.33%
PAHC - ZTS
41%
Loosely correlated
-3.81%
HLN - ZTS
38%
Loosely correlated
-0.61%
AMRX - ZTS
37%
Loosely correlated
-0.89%
More